✦ LIBER ✦

PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIVENESS-ANALYSIS STUDIES OF TRASTUZUMAB (HERCEPTIN™) IN TREATMENT OF HER2-POSITIVE BREAST CANCER

✍ Scribed by OA Le

Book ID: 118608893
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)70199-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN68 Cost-Effectiveness of HER-2-Positi

PCN68 Cost-Effectiveness of HER-2-Positive Metastatic-Breast-Cancer Treatment in Post-Herceptin Progression in Colombia

✍ Chicaiza, L.; Garcia-Molina, M.; Gamboa, O.; Castañeda, C.; Urrego, J.; Moreno, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJ

PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR HER-2 POSITIVE EARLY BREAST CANCER IN TAIWAN

✍ TY Chao; SC Chen; KJ Chang; HK Chang; DR Chen; MF Hou; RK Hsieh; WT Huang; LM Ts 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJ

PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE SAUDI ARABIAN SETTING

✍ H AlOmar; AS Zazaa; M AlFayyadh; JA Ray 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

PCN28 COST-UTILITY ANALYSIS IN A SPANISH

PCN28 COST-UTILITY ANALYSIS IN A SPANISH SETTING OF ADJUVANT THERAPY WITH TRASTUZUMAB (HERCEPTIN®) IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER

✍ C Polanco; M Carulla; X Badia; A Ramirez-Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN81 A Cost-Effectiveness Analysis of A

PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

✍ Buendia rodriguez, J.A.; Vallejos, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB